Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histidine triad nucleotide binding protein 1 pseudogene 2 (HINT1P2) is a genomic pseudogene derived from the HINT1 gene family. Pseudogenes are non-functional DNA segments that share homology with active genes but typically do not encode functional proteins[2][1]. They may arise from gene duplication or retrotransposition events and can acquire mutations that prevent normal transcription, translation, or protein function. Although some pseudogenes have regulatory effects—acting as noncoding RNA elements or modulating gene expression—the majority do not show protein-coding activity or direct disease relevance. HINT1P2 does not belong to traditional target families such as receptors, enzymes, or ion channels, and is not considered a therapeutic target. Its main relevance is as a genomic feature that may complicate molecular genetic studies through sequence similarity with the parent gene[2][4][1].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histidine triad nucleotide binding protein 1 pseudogene 2 (HINT1P2).